TriangleNCT01095757 · OUTCOME
Average Number of Days for Engraftment (Engraftment Defined as Absolute Neutrophil Count>500)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- days
- Interval / dispersion
- Standard Deviation
- Time frame
- Within the first 4 days following the first dose of Plerixafor
Groups in this outcome
Multiple Myeloma
Patients who receive a combination of Plerixafor, chemotherapy and G-CSF. Plerixafor : 240 µg/kg subcutaneous injection on the day that the ANC is \> 1500/mm3 and on each day of apheresis for a total of 4 aphereses or the target CD34 cell dose has been reached.
Lymphoma
Patients who receive a combination of Plerixafor, chemotherapy and G-CSF. Plerixafor : 240 µg/kg subcutaneous injection on the day that the ANC is \> 1500/mm3 and on each day of apheresis for a total of 4 aphereses or the target CD34 cell dose has been reached.
| Group | Source count |
|---|---|
| Multiple Myeloma | 10 |
| Lymphoma | 23 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Multiple Myeloma | 12.4 | 1.62 | Not reported | Not reported | Not reported |
| Lymphoma | 12.105 | 1.63 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 1.62
- value
- 12.4
- group Id
- OG001
- spread
- 1.63
- value
- 12.105
- denoms
- counts
- group Id
- OG000
- value
- 10
- group Id
- OG001
- value
- 23
- units
- Participants
- dispersion Type
- Standard Deviation
- groups
- description
- Patients who receive a combination of Plerixafor, chemotherapy and G-CSF. Plerixafor : 240 µg/kg subcutaneous injection on the day that the ANC is \> 1500/mm3 and on each day of apheresis for a total of 4 aphereses or the target CD34 cell dose has been reached.
- id
- OG000
- title
- Multiple Myeloma
- description
- Patients who receive a combination of Plerixafor, chemotherapy and G-CSF. Plerixafor : 240 µg/kg subcutaneous injection on the day that the ANC is \> 1500/mm3 and on each day of apheresis for a total of 4 aphereses or the target CD34 cell dose has been reached.
- id
- OG001
- title
- Lymphoma
- param Type
- MEAN
- reporting Status
- POSTED
- time Frame
- Within the first 4 days following the first dose of Plerixafor
- title
- Average Number of Days for Engraftment (Engraftment Defined as Absolute Neutrophil Count>500)
- type
- SECONDARY
- unit Of Measure
- days
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice